1. Home
  2. NIU vs TNXP Comparison

NIU vs TNXP Comparison

Compare NIU & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Niu Technologies

NIU

Niu Technologies

HOLD

Current Price

$2.03

Market Cap

161.6M

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.34

Market Cap

192.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NIU
TNXP
Founded
2014
2007
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.6M
192.9M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
NIU
TNXP
Price
$2.03
$12.34
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
439.9K
567.5K
Earning Date
05-18-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$25.54
$558.11
Revenue Next Year
$17.70
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.85
52 Week Low
$1.93
$10.03
52 Week High
$5.67
$69.65

Technical Indicators

Market Signals
Indicator
NIU
TNXP
Relative Strength Index (RSI) 38.73 49.93
Support Level N/A $12.08
Resistance Level $2.40 $13.17
Average True Range (ATR) 0.12 0.87
MACD 0.01 0.15
Stochastic Oscillator 22.11 61.08

Price Performance

Historical Comparison
NIU
TNXP

About NIU Niu Technologies

Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: